Prevention of demineralization

Prevention of demineralization refers to the therapeutic or physiological process of maintaining the mineral density of hard tissues, such as dental enamel and skeletal bone, by inhibiting the loss of calcium and phosphate ions (PMID: 24308333). It is not a discrete molecular target like a receptor or enzyme, but rather a clinical outcome resulting from the stabilization of the hydroxyapatite crystal lattice [NIH: Dental Caries]. In dentistry, the prevention of demineralization is the primary mechanism for avoiding dental caries, often achieved through the application of fluoride, which promotes the formation of acid-resistant fluorapatite (PMID: 27301326). In systemic health, it pertains to the maintenance of bone mineral density to prevent fractures in conditions like osteoporosis, where pharmacological agents like bisphosphonates are used to suppress osteoclast-mediated mineral resorption (PMID: 21855604). Consequently, while critical to pharmacology, this entry represents a therapeutic goal rather than a single biological target molecule.

Other names

RemineralizationDemineralization inhibitionEnamel protectionMaintenance of bone mineral densityInhibition of mineral loss

Prevention of demineralization is achieved by reducing the solubility of hydroxyapatite crystals (e.g., through fluoride incorporation) or by inhibiting the cellular or chemical pathways that drive mineral dissolution, such as osteoclast activity or acid production by cariogenic bacteria.